nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—Jaundice—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Lisinopril—Urinary tract infection—Epirubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Lisinopril—Neutropenia—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Lisinopril—Dysuria—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Lisinopril—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Lisinopril—Hepatitis—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Lisinopril—Sweating—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Lisinopril—Haematuria—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Lisinopril—Pharyngitis—Methotrexate—bone cancer	0.00133	0.00133	CcSEcCtD
Lisinopril—Urinary tract disorder—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Lisinopril—Photosensitivity reaction—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Lisinopril—Hepatobiliary disease—Epirubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Lisinopril—Weight increased—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Lisinopril—Epistaxis—Epirubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Lisinopril—Urethral disorder—Methotrexate—bone cancer	0.00132	0.00132	CcSEcCtD
Lisinopril—Weight decreased—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Lisinopril—Sinusitis—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Lisinopril—Hyperglycaemia—Doxorubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Lisinopril—Agranulocytosis—Epirubicin—bone cancer	0.00131	0.00131	CcSEcCtD
Lisinopril—Pneumonia—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Lisinopril—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Lisinopril—Hypersensitivity—Cisplatin—bone cancer	0.00128	0.00128	CcSEcCtD
Lisinopril—Bradycardia—Epirubicin—bone cancer	0.00128	0.00128	CcSEcCtD
Lisinopril—Renal failure—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Lisinopril—Erythema multiforme—Methotrexate—bone cancer	0.00127	0.00127	CcSEcCtD
Lisinopril—Neuropathy peripheral—Doxorubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Lisinopril—Jaundice—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Lisinopril—Rhinitis—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Lisinopril—Urinary tract infection—Doxorubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Lisinopril—Hepatitis—Epirubicin—bone cancer	0.00126	0.00126	CcSEcCtD
Lisinopril—Tinnitus—Methotrexate—bone cancer	0.00125	0.00125	CcSEcCtD
Lisinopril—Asthenia—Cisplatin—bone cancer	0.00125	0.00125	CcSEcCtD
Lisinopril—Pharyngitis—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Lisinopril—Sweating—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Lisinopril—Urinary tract disorder—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Lisinopril—Oedema peripheral—Epirubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Lisinopril—Haematuria—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Lisinopril—Urethral disorder—Epirubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Lisinopril—Hepatobiliary disease—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Lisinopril—Epistaxis—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Lisinopril—Angiopathy—Methotrexate—bone cancer	0.00122	0.00122	CcSEcCtD
Lisinopril—Sinusitis—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Lisinopril—Mediastinal disorder—Methotrexate—bone cancer	0.00121	0.00121	CcSEcCtD
Lisinopril—Agranulocytosis—Doxorubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Lisinopril—Chills—Methotrexate—bone cancer	0.0012	0.0012	CcSEcCtD
Lisinopril—Diarrhoea—Cisplatin—bone cancer	0.00119	0.00119	CcSEcCtD
Lisinopril—Erythema multiforme—Epirubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Lisinopril—Alopecia—Methotrexate—bone cancer	0.00119	0.00119	CcSEcCtD
Lisinopril—Bradycardia—Doxorubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Lisinopril—Mental disorder—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Lisinopril—Tinnitus—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Lisinopril—Erythema—Methotrexate—bone cancer	0.00117	0.00117	CcSEcCtD
Lisinopril—Malnutrition—Methotrexate—bone cancer	0.00117	0.00117	CcSEcCtD
Lisinopril—Flushing—Epirubicin—bone cancer	0.00117	0.00117	CcSEcCtD
Lisinopril—Rhinitis—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Lisinopril—Hepatitis—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Lisinopril—Pharyngitis—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Lisinopril—Urinary tract disorder—Doxorubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Lisinopril—Oedema peripheral—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Lisinopril—Dysgeusia—Methotrexate—bone cancer	0.00114	0.00114	CcSEcCtD
Lisinopril—Angiopathy—Epirubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Lisinopril—Urethral disorder—Doxorubicin—bone cancer	0.00114	0.00114	CcSEcCtD
Lisinopril—Mediastinal disorder—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Lisinopril—Back pain—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Lisinopril—Chills—Epirubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Lisinopril—Arrhythmia—Epirubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Lisinopril—Alopecia—Epirubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Lisinopril—Vomiting—Cisplatin—bone cancer	0.0011	0.0011	CcSEcCtD
Lisinopril—Vision blurred—Methotrexate—bone cancer	0.0011	0.0011	CcSEcCtD
Lisinopril—Mental disorder—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Lisinopril—Erythema multiforme—Doxorubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Lisinopril—Rash—Cisplatin—bone cancer	0.0011	0.0011	CcSEcCtD
Lisinopril—Dermatitis—Cisplatin—bone cancer	0.00109	0.00109	CcSEcCtD
Lisinopril—Erythema—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Lisinopril—Malnutrition—Epirubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Lisinopril—Ill-defined disorder—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Lisinopril—Tinnitus—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Lisinopril—Anaemia—Methotrexate—bone cancer	0.00108	0.00108	CcSEcCtD
Lisinopril—Flushing—Doxorubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Lisinopril—Flatulence—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Lisinopril—Tension—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Lisinopril—Dysgeusia—Epirubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Lisinopril—Nervousness—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Lisinopril—Back pain—Epirubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Lisinopril—Angiopathy—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Lisinopril—Malaise—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Lisinopril—Muscle spasms—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Lisinopril—Vertigo—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Lisinopril—Mediastinal disorder—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Lisinopril—Leukopenia—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Lisinopril—Chills—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Lisinopril—Arrhythmia—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Lisinopril—Nausea—Cisplatin—bone cancer	0.00103	0.00103	CcSEcCtD
Lisinopril—Vision blurred—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Lisinopril—Alopecia—Doxorubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Lisinopril—Cough—Methotrexate—bone cancer	0.00102	0.00102	CcSEcCtD
Lisinopril—Mental disorder—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Lisinopril—Ill-defined disorder—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Lisinopril—Malnutrition—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Lisinopril—Erythema—Doxorubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Lisinopril—Anaemia—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Lisinopril—Flatulence—Doxorubicin—bone cancer	0.000997	0.000997	CcSEcCtD
Lisinopril—Chest pain—Methotrexate—bone cancer	0.000994	0.000994	CcSEcCtD
Lisinopril—Myalgia—Methotrexate—bone cancer	0.000994	0.000994	CcSEcCtD
Lisinopril—Arthralgia—Methotrexate—bone cancer	0.000994	0.000994	CcSEcCtD
Lisinopril—Tension—Doxorubicin—bone cancer	0.000992	0.000992	CcSEcCtD
Lisinopril—Dysgeusia—Doxorubicin—bone cancer	0.00099	0.00099	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000987	0.000987	CcSEcCtD
Lisinopril—Malaise—Epirubicin—bone cancer	0.000986	0.000986	CcSEcCtD
Lisinopril—Discomfort—Methotrexate—bone cancer	0.000982	0.000982	CcSEcCtD
Lisinopril—Nervousness—Doxorubicin—bone cancer	0.000982	0.000982	CcSEcCtD
Lisinopril—Vertigo—Epirubicin—bone cancer	0.000982	0.000982	CcSEcCtD
Lisinopril—Syncope—Epirubicin—bone cancer	0.00098	0.00098	CcSEcCtD
Lisinopril—Leukopenia—Epirubicin—bone cancer	0.000978	0.000978	CcSEcCtD
Lisinopril—Back pain—Doxorubicin—bone cancer	0.000978	0.000978	CcSEcCtD
Lisinopril—Muscle spasms—Doxorubicin—bone cancer	0.000972	0.000972	CcSEcCtD
Lisinopril—Palpitations—Epirubicin—bone cancer	0.000966	0.000966	CcSEcCtD
Lisinopril—Confusional state—Methotrexate—bone cancer	0.000961	0.000961	CcSEcCtD
Lisinopril—Loss of consciousness—Epirubicin—bone cancer	0.000961	0.000961	CcSEcCtD
Lisinopril—Cough—Epirubicin—bone cancer	0.000954	0.000954	CcSEcCtD
Lisinopril—Anaphylactic shock—Methotrexate—bone cancer	0.000953	0.000953	CcSEcCtD
Lisinopril—Vision blurred—Doxorubicin—bone cancer	0.000953	0.000953	CcSEcCtD
Lisinopril—Infection—Methotrexate—bone cancer	0.000947	0.000947	CcSEcCtD
Lisinopril—Ill-defined disorder—Doxorubicin—bone cancer	0.000938	0.000938	CcSEcCtD
Lisinopril—Anaemia—Doxorubicin—bone cancer	0.000935	0.000935	CcSEcCtD
Lisinopril—Thrombocytopenia—Methotrexate—bone cancer	0.000933	0.000933	CcSEcCtD
Lisinopril—Chest pain—Epirubicin—bone cancer	0.000931	0.000931	CcSEcCtD
Lisinopril—Arthralgia—Epirubicin—bone cancer	0.000931	0.000931	CcSEcCtD
Lisinopril—Myalgia—Epirubicin—bone cancer	0.000931	0.000931	CcSEcCtD
Lisinopril—Anxiety—Epirubicin—bone cancer	0.000927	0.000927	CcSEcCtD
Lisinopril—Skin disorder—Methotrexate—bone cancer	0.000926	0.000926	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000924	0.000924	CcSEcCtD
Lisinopril—Hyperhidrosis—Methotrexate—bone cancer	0.000921	0.000921	CcSEcCtD
Lisinopril—Discomfort—Epirubicin—bone cancer	0.000919	0.000919	CcSEcCtD
Lisinopril—Malaise—Doxorubicin—bone cancer	0.000912	0.000912	CcSEcCtD
Lisinopril—Dry mouth—Epirubicin—bone cancer	0.00091	0.00091	CcSEcCtD
Lisinopril—Vertigo—Doxorubicin—bone cancer	0.000909	0.000909	CcSEcCtD
Lisinopril—Anorexia—Methotrexate—bone cancer	0.000909	0.000909	CcSEcCtD
Lisinopril—Syncope—Doxorubicin—bone cancer	0.000907	0.000907	CcSEcCtD
Lisinopril—Leukopenia—Doxorubicin—bone cancer	0.000905	0.000905	CcSEcCtD
Lisinopril—Confusional state—Epirubicin—bone cancer	0.000899	0.000899	CcSEcCtD
Lisinopril—Palpitations—Doxorubicin—bone cancer	0.000894	0.000894	CcSEcCtD
Lisinopril—Oedema—Epirubicin—bone cancer	0.000892	0.000892	CcSEcCtD
Lisinopril—Anaphylactic shock—Epirubicin—bone cancer	0.000892	0.000892	CcSEcCtD
Lisinopril—Hypotension—Methotrexate—bone cancer	0.000891	0.000891	CcSEcCtD
Lisinopril—Loss of consciousness—Doxorubicin—bone cancer	0.000889	0.000889	CcSEcCtD
Lisinopril—Infection—Epirubicin—bone cancer	0.000886	0.000886	CcSEcCtD
Lisinopril—Cough—Doxorubicin—bone cancer	0.000882	0.000882	CcSEcCtD
Lisinopril—Shock—Epirubicin—bone cancer	0.000878	0.000878	CcSEcCtD
Lisinopril—Thrombocytopenia—Epirubicin—bone cancer	0.000873	0.000873	CcSEcCtD
Lisinopril—Tachycardia—Epirubicin—bone cancer	0.000871	0.000871	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000868	0.000868	CcSEcCtD
Lisinopril—Skin disorder—Epirubicin—bone cancer	0.000866	0.000866	CcSEcCtD
Lisinopril—Hyperhidrosis—Epirubicin—bone cancer	0.000862	0.000862	CcSEcCtD
Lisinopril—Insomnia—Methotrexate—bone cancer	0.000862	0.000862	CcSEcCtD
Lisinopril—Arthralgia—Doxorubicin—bone cancer	0.000861	0.000861	CcSEcCtD
Lisinopril—Chest pain—Doxorubicin—bone cancer	0.000861	0.000861	CcSEcCtD
Lisinopril—Myalgia—Doxorubicin—bone cancer	0.000861	0.000861	CcSEcCtD
Lisinopril—Anxiety—Doxorubicin—bone cancer	0.000858	0.000858	CcSEcCtD
Lisinopril—Paraesthesia—Methotrexate—bone cancer	0.000856	0.000856	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000855	0.000855	CcSEcCtD
Lisinopril—Discomfort—Doxorubicin—bone cancer	0.000851	0.000851	CcSEcCtD
Lisinopril—Anorexia—Epirubicin—bone cancer	0.00085	0.00085	CcSEcCtD
Lisinopril—Dyspnoea—Methotrexate—bone cancer	0.00085	0.00085	CcSEcCtD
Lisinopril—Somnolence—Methotrexate—bone cancer	0.000847	0.000847	CcSEcCtD
Lisinopril—Dry mouth—Doxorubicin—bone cancer	0.000842	0.000842	CcSEcCtD
Lisinopril—Dyspepsia—Methotrexate—bone cancer	0.000839	0.000839	CcSEcCtD
Lisinopril—Hypotension—Epirubicin—bone cancer	0.000834	0.000834	CcSEcCtD
Lisinopril—Confusional state—Doxorubicin—bone cancer	0.000832	0.000832	CcSEcCtD
Lisinopril—Decreased appetite—Methotrexate—bone cancer	0.000829	0.000829	CcSEcCtD
Lisinopril—Oedema—Doxorubicin—bone cancer	0.000825	0.000825	CcSEcCtD
Lisinopril—Anaphylactic shock—Doxorubicin—bone cancer	0.000825	0.000825	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Methotrexate—bone cancer	0.000823	0.000823	CcSEcCtD
Lisinopril—Fatigue—Methotrexate—bone cancer	0.000822	0.000822	CcSEcCtD
Lisinopril—Infection—Doxorubicin—bone cancer	0.00082	0.00082	CcSEcCtD
Lisinopril—Pain—Methotrexate—bone cancer	0.000815	0.000815	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000813	0.000813	CcSEcCtD
Lisinopril—Shock—Doxorubicin—bone cancer	0.000812	0.000812	CcSEcCtD
Lisinopril—Thrombocytopenia—Doxorubicin—bone cancer	0.000808	0.000808	CcSEcCtD
Lisinopril—Insomnia—Epirubicin—bone cancer	0.000807	0.000807	CcSEcCtD
Lisinopril—Tachycardia—Doxorubicin—bone cancer	0.000806	0.000806	CcSEcCtD
Lisinopril—Skin disorder—Doxorubicin—bone cancer	0.000802	0.000802	CcSEcCtD
Lisinopril—Paraesthesia—Epirubicin—bone cancer	0.000801	0.000801	CcSEcCtD
Lisinopril—Hyperhidrosis—Doxorubicin—bone cancer	0.000798	0.000798	CcSEcCtD
Lisinopril—Dyspnoea—Epirubicin—bone cancer	0.000795	0.000795	CcSEcCtD
Lisinopril—Somnolence—Epirubicin—bone cancer	0.000793	0.000793	CcSEcCtD
Lisinopril—Anorexia—Doxorubicin—bone cancer	0.000787	0.000787	CcSEcCtD
Lisinopril—Feeling abnormal—Methotrexate—bone cancer	0.000785	0.000785	CcSEcCtD
Lisinopril—Dyspepsia—Epirubicin—bone cancer	0.000785	0.000785	CcSEcCtD
Lisinopril—Gastrointestinal pain—Methotrexate—bone cancer	0.000779	0.000779	CcSEcCtD
Lisinopril—Decreased appetite—Epirubicin—bone cancer	0.000775	0.000775	CcSEcCtD
Lisinopril—Hypotension—Doxorubicin—bone cancer	0.000771	0.000771	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Epirubicin—bone cancer	0.00077	0.00077	CcSEcCtD
Lisinopril—Fatigue—Epirubicin—bone cancer	0.000769	0.000769	CcSEcCtD
Lisinopril—Constipation—Epirubicin—bone cancer	0.000763	0.000763	CcSEcCtD
Lisinopril—Pain—Epirubicin—bone cancer	0.000763	0.000763	CcSEcCtD
Lisinopril—Urticaria—Methotrexate—bone cancer	0.000757	0.000757	CcSEcCtD
Lisinopril—Abdominal pain—Methotrexate—bone cancer	0.000754	0.000754	CcSEcCtD
Lisinopril—Body temperature increased—Methotrexate—bone cancer	0.000754	0.000754	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000752	0.000752	CcSEcCtD
Lisinopril—Insomnia—Doxorubicin—bone cancer	0.000747	0.000747	CcSEcCtD
Lisinopril—Paraesthesia—Doxorubicin—bone cancer	0.000741	0.000741	CcSEcCtD
Lisinopril—Dyspnoea—Doxorubicin—bone cancer	0.000736	0.000736	CcSEcCtD
Lisinopril—Feeling abnormal—Epirubicin—bone cancer	0.000735	0.000735	CcSEcCtD
Lisinopril—Somnolence—Doxorubicin—bone cancer	0.000734	0.000734	CcSEcCtD
Lisinopril—Gastrointestinal pain—Epirubicin—bone cancer	0.000729	0.000729	CcSEcCtD
Lisinopril—Dyspepsia—Doxorubicin—bone cancer	0.000727	0.000727	CcSEcCtD
Lisinopril—Decreased appetite—Doxorubicin—bone cancer	0.000717	0.000717	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000713	0.000713	CcSEcCtD
Lisinopril—Fatigue—Doxorubicin—bone cancer	0.000712	0.000712	CcSEcCtD
Lisinopril—Urticaria—Epirubicin—bone cancer	0.000709	0.000709	CcSEcCtD
Lisinopril—Constipation—Doxorubicin—bone cancer	0.000706	0.000706	CcSEcCtD
Lisinopril—Pain—Doxorubicin—bone cancer	0.000706	0.000706	CcSEcCtD
Lisinopril—Abdominal pain—Epirubicin—bone cancer	0.000705	0.000705	CcSEcCtD
Lisinopril—Body temperature increased—Epirubicin—bone cancer	0.000705	0.000705	CcSEcCtD
Lisinopril—Hypersensitivity—Methotrexate—bone cancer	0.000702	0.000702	CcSEcCtD
Lisinopril—Asthenia—Methotrexate—bone cancer	0.000684	0.000684	CcSEcCtD
Lisinopril—Feeling abnormal—Doxorubicin—bone cancer	0.00068	0.00068	CcSEcCtD
Lisinopril—Gastrointestinal pain—Doxorubicin—bone cancer	0.000675	0.000675	CcSEcCtD
Lisinopril—Pruritus—Methotrexate—bone cancer	0.000674	0.000674	CcSEcCtD
Lisinopril—Hypersensitivity—Epirubicin—bone cancer	0.000657	0.000657	CcSEcCtD
Lisinopril—Urticaria—Doxorubicin—bone cancer	0.000656	0.000656	CcSEcCtD
Lisinopril—Abdominal pain—Doxorubicin—bone cancer	0.000652	0.000652	CcSEcCtD
Lisinopril—Body temperature increased—Doxorubicin—bone cancer	0.000652	0.000652	CcSEcCtD
Lisinopril—Diarrhoea—Methotrexate—bone cancer	0.000652	0.000652	CcSEcCtD
Lisinopril—Asthenia—Epirubicin—bone cancer	0.00064	0.00064	CcSEcCtD
Lisinopril—Pruritus—Epirubicin—bone cancer	0.000631	0.000631	CcSEcCtD
Lisinopril—Dizziness—Methotrexate—bone cancer	0.00063	0.00063	CcSEcCtD
Lisinopril—Diarrhoea—Epirubicin—bone cancer	0.00061	0.00061	CcSEcCtD
Lisinopril—Hypersensitivity—Doxorubicin—bone cancer	0.000608	0.000608	CcSEcCtD
Lisinopril—Vomiting—Methotrexate—bone cancer	0.000606	0.000606	CcSEcCtD
Lisinopril—Rash—Methotrexate—bone cancer	0.000601	0.000601	CcSEcCtD
Lisinopril—Dermatitis—Methotrexate—bone cancer	0.0006	0.0006	CcSEcCtD
Lisinopril—Headache—Methotrexate—bone cancer	0.000597	0.000597	CcSEcCtD
Lisinopril—Asthenia—Doxorubicin—bone cancer	0.000592	0.000592	CcSEcCtD
Lisinopril—Dizziness—Epirubicin—bone cancer	0.00059	0.00059	CcSEcCtD
Lisinopril—Pruritus—Doxorubicin—bone cancer	0.000584	0.000584	CcSEcCtD
Lisinopril—Vomiting—Epirubicin—bone cancer	0.000567	0.000567	CcSEcCtD
Lisinopril—Nausea—Methotrexate—bone cancer	0.000566	0.000566	CcSEcCtD
Lisinopril—Diarrhoea—Doxorubicin—bone cancer	0.000565	0.000565	CcSEcCtD
Lisinopril—Rash—Epirubicin—bone cancer	0.000562	0.000562	CcSEcCtD
Lisinopril—Dermatitis—Epirubicin—bone cancer	0.000562	0.000562	CcSEcCtD
Lisinopril—Headache—Epirubicin—bone cancer	0.000559	0.000559	CcSEcCtD
Lisinopril—Dizziness—Doxorubicin—bone cancer	0.000546	0.000546	CcSEcCtD
Lisinopril—Nausea—Epirubicin—bone cancer	0.00053	0.00053	CcSEcCtD
Lisinopril—Vomiting—Doxorubicin—bone cancer	0.000525	0.000525	CcSEcCtD
Lisinopril—Rash—Doxorubicin—bone cancer	0.00052	0.00052	CcSEcCtD
Lisinopril—Dermatitis—Doxorubicin—bone cancer	0.00052	0.00052	CcSEcCtD
Lisinopril—Headache—Doxorubicin—bone cancer	0.000517	0.000517	CcSEcCtD
Lisinopril—Nausea—Doxorubicin—bone cancer	0.00049	0.00049	CcSEcCtD
